Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Elfangor
    Junior Member
    • Mar 2016
    • 4

    miRDeep2 output scores

    Hello everyone, I'm using miRDeep2 to predict novel miRNAs in a Differential Expresion experiment from some muscle samples.

    The thing is that when running miRDeep2, everything goes fine, but the problem comes when analyzing the results.

    Does anyone know how to interpret the miRDeep2 scores?. The program generates a table with a header which tells you that the greater the miRDeep2 score is, the greater the probability is that this novel miRNA es a false positive, so by this, I understand that what is valuable to predict a good novel miRNA is that this miRNA has a low mirDeep2 score, near 0 or negative.

    BUT, when going into the list of novel predicted miRNAs, which are designated by their coordinates, I find that most, if not all, of Differentially expressed predicted novel miRNAs, appear to have very high miRDeep2 scores, so according to what I mentioned above, those should have a very high probability of being false positives. BUT, as a variable within this list of novel predicted miRNAs, there's a field telling you the "estimated probability that the miRNA candidate is a true positive" which tells you that the higher the miRDeep2 is, the higher this probability of being a true positive is.

    I find it conflictive, as firstly miRDeep2 score seems to be desirable if having a low value, but then it turns to the inverse interpretation, as it should have a high value.

    Did someone analyze results from miRDeep2? I'm trying to select some desirable novel miRNAs to validate them via rt-qPCR but this is blowing my mind...

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Working...